Advisory Services Network, LLC Tricida, Inc. Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.14 - $12.49 $238 - $21,233	1,700 New	1,700 $0
Q3 2021 Nov 05, 2021	SELL	$3.56 - $4.64 $21,182 - $27,607	-5,950 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.95 - $5.41 $23,502 - $32,189	5,950 New	5,950 $26,000
Q1 2021 May 24, 2021	SELL	$4.52 - $7.8 $1,581 - $2,730	-350 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$4.37 - $9.46 $1,092 - $2,365	-250 Reduced 41.67%	350 $2,000

Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $5,136 - $16,158	600 New	600 $5,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.